カスパーゼ阻害剤を含む、TGF-βに起因する障害を治療または予防するための医薬およびその応用

• 收藏
• 分享

专利权人:

学校法人同志社

发明人:

小泉 範子,奥村 直毅

申请号：

JP2017547583

公开号：

JP6273636B2

申请日:

2016.12.22

申请国别(地区):

JP

年份:

2018

代理人:

摘要：

Provided is a drug or method for treating or preventing a condition, disorder, or disease of the corneal endothelium caused by transforming growth facto r-β (TGF-β) signals and/or mitochondrial abnormalities in corneal endothelial cells. The present invention provides a drug which includes caspase inhibitors, and which is for treating or preventing a condition, disorder, or disease of the corneal endothelium caused by TGF-β signals and/or mitochondrial abnormalities in corneal endothelial cells. In the preferred embodiment, the condition, disorder, or disease of the corneal endothelium is Fuchs corneal endothelial dystrophy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/